Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
出版年份 2022 全文链接
标题
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
作者
关键词
-
出版物
BMJ-British Medical Journal
Volume -, Issue -, Pages e068632
出版商
BMJ
发表日期
2022-03-03
DOI
10.1136/bmj-2021-068632
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines
- (2021) Edward H. Livingston JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
- (2021) Ayelet Grupper et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients
- (2021) Smaragdi Marinaki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Serological response to mRNA COVID-19 vaccines in IBD patients receiving biological therapies
- (2021) Serre-Yu Wong et al. GASTROENTEROLOGY
- Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
- (2021) Nicholas A Kennedy et al. GUT
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
- (2021) Fulvia Pimpinelli et al. Journal of Hematology & Oncology
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
- (2021) Liane Rabinowich et al. JOURNAL OF HEPATOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration
- (2021) Stephanie G. Yi et al. TRANSPLANTATION
- Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
- (2021) Johannes Korth et al. Viruses-Basel
- Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
- (2021) Paddy Ssentongo et al. Scientific Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- BNT162b2 COVID ‐19 vaccine is significantly less effective in patients with hematologic malignancies
- (2021) Katrin Herzog Tzarfati et al. AMERICAN JOURNAL OF HEMATOLOGY
- Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
- (2021) Nathalie Chavarot et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficiency of a boost with a third dose of anti‐SARS‐CoV‐2 messenger RNA‐based vaccines in solid organ transplant recipients
- (2021) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impaired anti‐SARS‐CoV‐2 humoral and cellular immune response induced by Pfizer‐BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
- (2021) Monica Miele et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Negative immune responses to two‐dose mRNA COVID‐19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring
- (2021) Marta Crespo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients
- (2021) Marta Kantauskaite et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
- (2021) Tina Schmidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- AB0606 IMPACT OF ABDOMINAL AORTIC CALCIFICATION AND SERUM CREATININE-TO-CYSTATIN C RATIO TO BONE FRAGILITY FRACTURE
- (2021) I. Yoshii ANNALS OF THE RHEUMATIC DISEASES
- AB0546 5 YEARS FOLLOW-UP OF PSORIATIC ARTHRITIS PATIENTS TREATED ACCORDING TREAT-TO-TARGET STRATEGY. PRELIMINARY RESULTS
- (2021) P. Tremaskina et al. ANNALS OF THE RHEUMATIC DISEASES
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
- (2021) Maria Prendecki et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
- (2021) Paola Ghione et al. BLOOD
- Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms
- (2021) Onima Chowdhury et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
- (2021) Lee M. Greenberger et al. CANCER CELL
- Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine
- (2021) Maria Gavriatopoulou et al. CLINICAL AND EXPERIMENTAL MEDICINE
- SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients
- (2021) Darius F. Ruether et al. Clinical Gastroenterology and Hepatology
- Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients
- (2021) Alessandra Mazzola et al. CLINICAL INFECTIOUS DISEASES
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
- (2021) David W. Eyre et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Poor humoral and T-cell response to two-dose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant recipients
- (2021) René Schramm et al. Clinical Research in Cardiology
- Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS‐CoV‐2 vaccine
- (2021) Ayelet Grupper et al. CLINICAL TRANSPLANTATION
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
- (2021) David Hagin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
- (2021) Evangelos Terpos et al. Journal of Hematology & Oncology
- Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
- (2021) Clément Danthu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients
- (2021) Hagai Ligumsky et al. JNCI-Journal of the National Cancer Institute
- A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponse
- (2021) Timm H. Westhoff et al. KIDNEY INTERNATIONAL
- Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
- (2021) Samuel D. Stampfer et al. LEUKEMIA
- Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
- (2021) Sokratis A. Apostolidis et al. NATURE MEDICINE
- Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
- (2021) Ana C. Medeiros-Ribeiro et al. NATURE MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
- (2021) Emire Seyahi et al. RHEUMATOLOGY INTERNATIONAL
- Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies
- (2021) Tammy Hod et al. TRANSPLANTATION
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Serological response to COVID-19 vaccination in patients with cancer older than 80 years
- (2021) Daniela Iacono et al. Journal of Geriatric Oncology
- Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
- (2021) Florent Malard et al. Blood Cancer Journal
- Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia
- (2021) H. Parry et al. Blood Cancer Journal
- Covid-19: UK will offer third vaccine dose to severely immunosuppressed people
- (2021) Jacqui Wise BMJ-British Medical Journal
- Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination
- (2021) Peter M. Izmirly et al. Arthritis & Rheumatology
- Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
- (2021) Sean H Lim et al. Lancet Haematology
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
- (2021) Shabir A Madhi et al. Lancet HIV
- Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
- (2021) Amir Massarweh et al. JAMA Oncology
- Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment
- (2021) Noa Eliakim-Raz et al. JAMA Oncology
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
- (2021) Evangelos Terpos et al. Cancers
- Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
- (2021) Abed Agbarya et al. Cancers
- Responses to SARS-CoV-2 Vaccination in Patients with Cancer (ReCOVer Study): A Prospective Cohort Study of the Hellenic Cooperative Oncology Group
- (2021) Helena Linardou et al. Cancers
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
- (2021) Hector Rincon-Arevalo et al. Science Immunology
- Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines
- (2021) Madhusudhanan Narasimhan et al. Vaccines
- Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
- (2021) Jassin Rashidi-Alavijeh et al. Vaccines
- Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
- (2021) Yu-Jing Fan et al. Vaccines
- REDUCED HUMORAL IMMUNE RESPONSE AFTER BNT162B2 COVID-19 MRNA VACCINATION IN CANCER PATIENTS UNDER ANTI-NEOPLASTIC TREATMENT
- (2021) M. Peeters et al. ESMO Open
- Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2; a prospective study
- (2021) Maria Gavriatopoulou et al. Blood Advances
- The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
- (2021) Satveer K Mahil et al. Lancet Rheumatology
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
- (2021) Laura Boekel et al. Lancet Rheumatology
- Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
- (2021) Andrea Rubbert-Roth et al. Lancet Rheumatology
- COVID-19 vaccination for patients with primary immunodeficiency
- (2021) Chaim M. Roifman et al. LymphoSign Journal-The Journal of Inherited Immune Disorders
- SARS‐CoV‐2‐specific humoral and cell‐mediated immune responses after immunization with inactivated COVID‐19 vaccine in kidney transplant recipients (CVIM 1 study)
- (2021) Jackrapong Bruminhent et al. AMERICAN JOURNAL OF TRANSPLANTATION
- High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
- (2021) Flora Zagouri et al. BREAST
- Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients
- (2021) Noga Shem‐Tov et al. BRITISH JOURNAL OF HAEMATOLOGY
- T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
- (2021) Vincenzo Marasco et al. BRITISH JOURNAL OF HAEMATOLOGY
- Immunogenicity and Safety of COVID-19 Vaccine BNT162b2 for Patients with Solid Cancer: A Large Cohort Prospective Study from a Single Institution
- (2021) Vincenzo Di Noia et al. CLINICAL CANCER RESEARCH
- Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity
- (2021) Amy C Sherman et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
- (2021) Einat S. Shmueli et al. EUROPEAN JOURNAL OF CANCER
- Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
- (2021) Nils Jedicke et al. HIV MEDICINE
- SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
- (2021) Hadis Fathizadeh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
- (2021) Lorenzo Canti et al. Journal of Hematology & Oncology
- Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
- (2021) Samuel Bitoun et al. Journal of Hematology & Oncology
- Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study
- (2021) Anat Achiron et al. JOURNAL OF NEUROIMMUNOLOGY
- B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
- (2021) Eva Schrezenmeier et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients
- (2021) Dominique Bertrand et al. KIDNEY INTERNATIONAL
- Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients
- (2021) Maria Prendecki et al. LANCET
- Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients
- (2021) Gianpiero D’Offizi et al. LIVER INTERNATIONAL
- Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
- (2021) Rachna T. Shroff et al. NATURE MEDICINE
- Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
- (2021) Michalis Liontos et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
- (2021) Samuel K Shinjo et al. RHEUMATOLOGY
- Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies
- (2021) Ahya Ali et al. VACCINE
- Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
- (2021) Michalis Liontos et al. Vaccines
- Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients
- (2021) Monika Lindemann et al. Vaccines
- Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH Project
- (2021) Alicja Dębska-Ślizień et al. Vaccines
- Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
- (2021) A. Grinshpun et al. ESMO Open
- Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
- (2021) Kristin Schmiedeberg et al. Lancet Rheumatology
- COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter
- (2020) Marcus R. Pereira et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients
- (2020) Jung-Hwan Lee et al. VACCINE
- Comprehensive review of implications of COVID‐19 on clinical outcomes of cancer patients and management of solid tumors during the pandemic
- (2020) Ankit Madan et al. Cancer Medicine
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 and thrombosis: From bench to bedside
- (2020) Mohammad A.M. Ali et al. TRENDS IN CARDIOVASCULAR MEDICINE
- RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Oriol Manuel et al. CLINICAL TRANSPLANTATION
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Hepatitis B virus vaccination in HIV-infected people: A review
- (2017) François-Xavier Catherine et al. Human Vaccines & Immunotherapeutics
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients
- (2014) J. Westra et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Influenza vaccination in immunocompromised patients: efficacy and safety
- (2014) Delphine Zbinden et al. Immunotherapy
- Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology
- (2012) C. R. Beck et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis
- (2010) A Anema et al. HIV MEDICINE
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now